Cargando…
Can we use a simple blood test to reduce unnecessary adverse effects from radiotherapy by timely identification of radiotherapy-resistant rectal cancers? MeD-Seq rectal study protocol
BACKGROUND: Chemoradiation therapy (CRT) followed by surgery is currently the standard of care to treat patients with locally advanced rectal cancer (LARC). CRT reduces local recurrences, but is associated with significant damage to the surrounding healthy tissue that can severely impact patients qu...
Autores principales: | Mens, D. M., van Rees, J. M., Wilting, S. M., Verhoef, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696698/ https://www.ncbi.nlm.nih.gov/pubmed/38049783 http://dx.doi.org/10.1186/s12885-023-11671-y |
Ejemplares similares
-
Image-guided radiotherapy in an orthotopic mouse model of rectal cancer
por: Nicolas, Adele M., et al.
Publicado: (2022) -
Clinical prediction models assessing response to radiotherapy for rectal cancer: protocol for a systematic review
por: Karageorgou, Margarita, et al.
Publicado: (2022) -
In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014) -
Does setup on rectal wall improve rectal cancer boost radiotherapy?
por: Kleijnen, Jean-Paul J. E., et al.
Publicado: (2018) -
Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)